Lv1
52 积分 2023-10-11 加入
Facts and Hopes in Radioimmunotherapy of Oligometastatic Disease
2天前
已完结
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study
1个月前
已完结
Classic Hodgkin Lymphoma in Adolescents and Young Adults
4个月前
已完结
Targeting HSP90 in cancer: advances in the development of inhibitors, mechanisms of action, and therapeutic applications
4个月前
已关闭
METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N 6‐methyladenosine‐dependent primary MicroRNA processing
6个月前
已完结
Preclinical Development and Comparison of [99mTc]Tc/[177Lu]Lu-Labeled Anti-Trop2 Fc-Fused Nanobodies as Pancreatic Cancer Theranostics
7个月前
已完结
The molecular blueprint of targeted radionuclide therapy
7个月前
已完结
Radiopharmaceuticals as combinatorial partners for immune checkpoint inhibitors
7个月前
已完结
Lymphoid organ-targeted nanomaterials for immunomodulation of cancer, inflammation, and beyond
8个月前
已完结
皖公网安备34019202002308
